Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with extensive-stage small cell lung cancer

被引：0
|
作者：
Spigel, D. R.
Hainsworth, J. D.
Yardley, D. A.
Burris, H. A., III
Farley, C.
Zubkus, J.
Meng, C.
Murphy, P.
Saez, R.
Greco, F. A.
机构：
[1] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[2] Watson Clin Ctr Res, Lakeland, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18130
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
    Spigel, David R.
    Greco, F. Anthony
    Zubkus, John D.
    Murphy, Patrick B.
    Saez, Ruben A.
    Farley, Cindy
    Yardley, Denise A.
    Burris, Howard A., III
    Hainsworth, John D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1555 - 1560
  • [2] Irinotecan, carboplatin, and bevacizumab in untreated extensive-stage small-cell lung cancer
    Spigel, David R.
    Hainsworth, John D.
    Burris, Howard A.
    Yardley, Denise A.
    Farley, Cindy
    Meng, Christina
    Greco, Anthony F.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S391 - S391
  • [3] Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer
    Socinski, MA
    Neubauer, MA
    Olivares, J
    Ketchel, S
    Tynan, M
    Moore, M
    Lee, JH
    Davis, K
    Schell, M
    Garfield, D
    LUNG CANCER, 2003, 40 (01) : 91 - 97
  • [4] Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with limited-stage small cell lung cancer
    Zubkus, J. D.
    Spigel, D. R.
    Greco, F. A.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E.
    Farley, C.
    Patton, J. F.
    Hart, L.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Implications for practice: phase II/III trial of carboplatin and irinotecan for elderly patients with extensive-stage small-cell lung cancer in Japan
    Maheshwari, Shipra
    Gentzler, Ryan D.
    JOURNAL OF THORACIC DISEASE, 2024, 16 (09) : 6342 - 6346
  • [6] A Phase I Clinical Trial of Irinotecan and Carboplatin in Patients with Extensive Stage Small Cell Lung Cancer
    Crabb, Simon J.
    Bradbury, Jennifer
    Nolan, Luke
    Selman, Diana
    Muthuramalingam, Sethupathi R.
    Cave, Judith
    Johnson, Peter W. M.
    Ottensmeier, Christian
    CHEMOTHERAPY, 2012, 58 (04) : 257 - 263
  • [7] Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: A phase II trial of the minnie pearl cancer research network
    Spigel, David R.
    Hainsworth, John D.
    Simons, Lisa
    Meng, Christina
    Burris, Howard A., III
    Yardley, Denise A.
    Grapski, Richard
    Schreeder, Marshall
    Mallidi, Padmaja V.
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (09) : 854 - 861
  • [8] A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer
    Horn, Leora
    Zhao, Zhiguo
    Sandler, Alan
    Johnson, David
    Shyr, Yu
    Wolff, Steven
    DeVore, Russell F.
    Laskin, Janessa
    CLINICAL LUNG CANCER, 2011, 12 (03) : 161 - 165
  • [9] Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study
    Ready, Neal E.
    Dudek, Arkadiusz Z.
    Pang, Herbert H.
    Hodgson, Lydia D.
    Graziano, Stephen L.
    Green, Mark R.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4436 - 4441
  • [10] Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?
    Roviello, Giandomenico
    Generali, Daniele
    CURRENT CANCER DRUG TARGETS, 2016, 16 (03) : 209 - 214
12345